New York State Common Retirement Fund’s Black Diamond Therapeutics BDTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.1K Buy
+30,300
New +$74.1K ﹤0.01% 2958
2025
Q2
Sell
-4,400
Closed -$6.82K 3212
2025
Q1
$6.82K Hold
4,400
﹤0.01% 3111
2024
Q4
$9.42K Hold
4,400
﹤0.01% 3115
2024
Q3
$19.1K Sell
4,400
-16,900
-79% -$92K ﹤0.01% 3047
2024
Q2
$99.3K Buy
+21,300
New +$114K ﹤0.01% 2857
2022
Q3
Sell
-194
Closed 3281
2022
Q2
$0 Sell
194
-10,500
-98% -$24.4K ﹤0.01% 3477
2022
Q1
$30K Hold
10,694
﹤0.01% 3251
2021
Q4
$57K Sell
10,694
-6,028
-36% -$42.1K ﹤0.01% 3197
2021
Q3
$141K Buy
16,722
+74
+0.4% +$731 ﹤0.01% 3030
2021
Q2
$203K Buy
16,648
+148
+0.9% +$2.93K ﹤0.01% 3036
2021
Q1
$400K Hold
16,500
﹤0.01% 2546
2020
Q4
$529K Buy
16,500
+3,200
+24% +$105K ﹤0.01% 2325
2020
Q3
$402K Buy
13,300
+2,400
+22% +$73K ﹤0.01% 2321
2020
Q2
$460K Buy
+10,900
New +$401K ﹤0.01% 2259

Other funds holding BDTX

New York State Common Retirement Fund's BDTX Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Black Diamond Therapeutics (BDTX) in Q2 2026: 30,300 shares worth $56.1K. The stake represents ﹤0.01% of the portfolio and ranks #2958 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in BDTX as recently as Q1 2025.

New York State Common Retirement Fund first reported a position in BDTX in Q2 2020 and has held it in 14 quarters since. The position peaked at $529K in Q4 2020. 11 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

  • New York State Common Retirement Fund held 30,300 shares of Black Diamond Therapeutics worth $56.1K as of Q2 2026.
  • Black Diamond Therapeutics was a new New York State Common Retirement Fund position in Q2 2026.
  • Black Diamond Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2958 holding.
  • New York State Common Retirement Fund first reported a position in Black Diamond Therapeutics in Q2 2020 and has held it in 14 quarters since.
  • New York State Common Retirement Fund's Black Diamond Therapeutics position peaked at $529K in Q4 2020.
  • 11 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.